Meanwhile, we observed a positive association between TNFRSF14 elevation and upregulation of M2 TAMs markers, CD163 (r = 0.91, p < 0.0001, Fig. 7I) and CD206 (r = 0.96, p < 0.0001, Fig. 7J) in GBM samples. This evidence concerns the gene TNFRSF14 and glioblastoma.